
David Kaiser Interviewed at Octane's Medical Innovation Forum in Irvine, California
Hey, I'd like to welcome you to another episode of Mission Matters. My name is Adam Torres, and if you'd like to apply to be a guest in the show, just head on over to missionmatters. com and click on be our guest to apply. All right. So today I'm in Irvine, California at the Medical Innovation Forum powered by Octane. And my guest today is David Kaiser. David. David. Welcome to the show. Hi, Adam. How are you? Oh, man, I'm having all kinds of fun. And let me tell you, this is my second Octane conference, and there is energy in the room. How are you liking the conference so far? I love it. It's really informative. Great potential partners, great VCs, investors learning experience. So what brings you here today? So we're presenting today and the purpose of our presentation is to expose our brand and our solution to potential partners as well as investors. So tell me a little bit more about the company. Yeah. Memory Care AI was created. Imagine a world where memory loss the fear of memory loss no longer dictates your future or Where families no longer have to endure the heart wrenching journey of witnessing a family member really disintegrate before their eyes, right? They can't remember what they remembered, or they don't recognize a loved one. And really, that's our mission. And, you know, the issue today is there's just not enough geriatricians, there's not enough neurologists, there's not enough physicians to handle the impact of what's coming. With people who suffer from Alzheimer's and related dementias. So we created this SAS platform. It's incredibly cool because we're using digital humans. That interface with the patient, they could do this at home and provides neuropsych testing. It provides an analysis of their speech and several biomarkers within that speech. And it analyzes facial expressions, it analyzes speech prosody. And what we'll do is transcribe that information through our AI system and summarize it. And then assign CPT codes, which are insurance billing codes for the physician and send that off to their physician. And now the physician has a comprehensive overview of where the patient is cognitively. Today, they are providing one test once a year to a potential patient. And it just gives a glimpse into where they may be cognitively. And this happens once a year. And it's just not enough. And so 75 percent of all people that have Alzheimer's go undiagnosed. That's a monster number. That is, yeah. You know, but we, by these digital humans we've created, incidentally, what goes on in the, what powers these digital humans is our back end, is our large language model that has over 2 million Alzheimer's patient records. Wow. So this provides tremendous accuracy in our, in our digital humans observations. Yeah. So we think it's going to create a huge impact in this Alzheimer's fight. Where did you I know you're a founder of the company. Where did you come up with this idea? Like when did, how did this evolve? So you really want to know? So I've been in behavioral health and neuroscience for Around 17 years. Yeah. But as I worked with scientists and I worked with doctors, but as a chief operating officer or a chief marketing officer, and I just knew there had to be a better way that the status quo good enough, isn't good enough. Right. And I'll tell you how it came to me. I've been searching high and low to, for my purpose and how I can best serve others. And. This came to me in a meditation. I am. I meditate, I meditate, I meditate, right? And I was asking, I was asking, show me my purpose, how you want to use me to serve others. And so watching my grandmother and mother go through it, I just came to me in January of 24 and I jumped up and jumped on it and recruited a phenomenal team of neuroscientists and Mayo Clinic MD. And others who are fantastic. And. Just took off running, man. Yeah, it was a vision and the vision is now reality. In fact, we're one year ahead of schedule. Wow. It's amazing. And I feel like many people have that had experiences with parents or grandparents or something else and they, and they accept that as a status quo. That's exactly right. Like And by the way, when you're talking about finding purpose and things like this, come on, you're on a platform called Mission Matter. Right, I didn't think about that. Come on, you're in good company. It aligns, right? Yeah, but in all reality though, like, that's like, not accepting the status quo. I mean, at some point, somebody was like, hey, I don't want to go to the outhouse. We need indoor plumbing, and people are like, what do you mean? Why do we need indoor plumbing? At some point, like, somebody has to not accept a status quo and has to move something forward. We push the boundaries. Because what happens with Alzheimer's patients or relate patients with related dementias, they're put in a nursing home and forgotten about. Yeah, that's it, yeah. Right? But our digital human not only does a thorough cognitive assessment of t
Mission Matters Business Podcast with Adam Torres
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Listen to Octane's Medical Innovation Forum coverage. In this episode, Adam Torres interviews David Kaiser, Co-Founder and CEO at MemoryCareAI, explore MemoryCareAI and Octane's Medical Innovation Forum.
Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule.
Apply to be a guest on our podcast:
https://missionmatters.lpages.co/podcastguest/
Visit our website:
More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia
Learn more about your ad choices. Visit podcastchoices.com/adchoices